Evidence-based health, wellness, and the science of living well.

New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout

Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found

A brief hantavirus update, some good news about death, and more health news from Morning Rounds

Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.

“Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on the Amish and health care.

“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.

Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.

Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks

Medicaid work requirements, fast-tracked funding for experimental Ebola vaccines, and more health news from Morning Rounds

Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.

It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.

A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.

While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers involved in the network said the cuts have damaged relationships with experts…

“Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine ideals,” First Opinion author writes.

A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.

States are racing to implement the new requirements by the start of next year.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.